My Profile   |   Print Page   |   Contact Us   |   Sign In   |   Register
ASAP Blog
Blog Home All Blogs
Welcome to ASAP Blog, the best place to stay current regarding upcoming events, member companies, the latest trends, and leaders in the industry. Blogs are posted at least once a week; members may subscribe to receive notifications when new blogs are posted by clicking the "Subscribe" link above.

 

Search all posts for:   

 

Top tags: alliance management  alliances  collaboration  partnering  alliance  alliance managers  partner  partners  alliance manager  partnerships  ecosystem  The Rhythm of Business  partnership  governance  Jan Twombly  biopharma  Strategic Alliance Magazine  Eli Lilly and Company  Vantage Partners  IoT  ASAP BioPharma Conference  healthcare  NetApp  strategy  2015 ASAP Global Alliance Summit  Cisco  communication  IBM  innovation  Strategic Alliances 

2016 ASAP European Alliance Summit to Address the Latest Developments in the Evolving Partnering Ecosystem

Posted By Cynthia B. Hanson, Wednesday, August 31, 2016
Updated: Saturday, August 27, 2016

This year’s ASAP European Alliance Summit scheduled for Nov. 3-4 hosted at the Royal Garden Hotel in London, England, should be particularly interesting given the recent news of the United Kingdom’s vote to depart from the European Union. How it might impact European alliances is certain to be addressed in the packed schedule of sessions and speakers with the Summit theme “The New Ecosystem for Partnerships.” The joint venture between ASAP and Thought Leader Global provides alliance managers in Europe and elsewhere with a window into the most current and cutting edge developments in their industries, as well as the latest in cross-industry partnering in an evolving ecosystem heavily impacted by trends taking place in the Internet of Things (IoT), healthcare, smart cities, the cloud, automotive trends, telecom, digital, and other areas.

 

Session speakers are being drawn from a pool of 30 directors of strategic alliances, multi- and cross-industry collaborators,  and collaboration business gurus.  Participants are free to choose sessions from two different streams of presentations throughout the conference.  The event will include at least 30 case study presentations, representation from over 15 different countries and over 10 different industries – from biopharma/life sciences, to energy, consumer goods, manufacturing, and technology.

 

You won’t want to miss industry experts and pundits talking about the latest advancements in their industries, such as:

  • Ole Kjems Sørensen, SVP, Head of Partnerships, DONG Energy
  • Michael Hilsenrath, Alliance Partner Business Development, Vodafone UK
  • Nick Jenkins, Marketing Partnerships and Ecosystem Director, UK, Facebook
  • Yuval Dvir, Head of EMEA Online Partnerships, Google for Work, Google
  • Hans Lindner, Head Global External Innovation and Alliances, Bayer
  • Sebastien Collignon, Director IOT Ecosystem EMEAR, Cisco
  • Michael Sumpter, Head of Alliance Mgmt, Servier Monde
  • Denis Gautheret, Vice President Alliances & Business Development, Deutsche Telekom
  • Ruben Garcia Santos, CSAP, Programme Manager Strategic Partnerships, Novo Nordisk Haemophilia Foundation
  • Sarah Sanders, Director of Partnerships, Ecosystem Strategy & Partnerships, GSMA
  • Michael Moser, CSAP, Alliances Network Collaboration, Dassault
  • Nils Bosma, GM JV Asset Management, Shell
  • Patrick Nielly, SVP Strategic Alliances, Ipsen
  • Steve Twait, CSAP, VP, Alliance and Integration Mgmt, AstraZeneca
  • Aileen Smith, Head, Digital Ecosystem Development, Huawei
  • Mikael Bäck, Global Head of Strategy Development & Portfolio, Ericsson
  • Anoop Nathwani, President UK Chapter, ASAP
  • Annick de Swaef, CSAP, President Benelux Chapter, ASAP
  • Frank Grams, VP, Head Alliance Management & Transactions, Sanofi R&D
  • Cindy Warren, VP, Business Development Neuroscience, Janssen Business Development
  • Moneshia zu Eltz, Head of Strategic Alliances and Corporate Venturing, Philips
  • Jean-Marc Gottero, VP A&C Cloud EMEA, Oracle
  • Heather Fraser, Global Lead, Life Sciences & Healthcare, IBM Institute for Business Value
  • Alistair Dixon, Senior Director, Global Alliance Mgmt, Takeda

Tap into a wide range of engaging and valuable topics presented by the best and brightest in the industry, such as:

  • New Partnership Models in a Digital LandscapeFacebook 
  • From Bilateral Alliances to Portfolios and EcosystemSanofi, Philips, IBM, Cisco 
  • Digital EcosystemsSyngenta, Huawei 
  • Ensuring a Collaborative Mindset as the Success Factor for Strategic Alliances Unilever 
  • Centers of Excellence: Reaching Higher Levels of Development in your Alliance RelationshipsTakeda 
  • Maximizing Value though DivestmentsAstraZeneca 
  • Managing Channel at a Time of Market TransformationOracle 
  • Best Practice on R&D, Innovation and Partnerships with AcademiaBayer 
  • Setting Up an Alliance Management Function in Your OrganizationServier Monde 
  • Making your Alliance GlobalJohnson & Johnson 
  • How to Manage IP in Innovation and Technology PartnershipsLundbeck 
  • Develop the Design & Managing Partnership ModelsGSMA 

Don’t miss Europe’s premiere partnering opportunity for managers, directors, CEOs, CFOs, and others interested in the latest trends in strategic alliances, business development, joint ventures, M&A, corporate development, portfolio management, integration units, human resources, programme management, change management, corporate strategy, strategy execution, and PMO.

 

For a list of emerging trends and topics, speakers, attending corporations, and/or to register or download the events brochure, visit www.asapweb.org/eusummit .

Tags:  ASAP European Alliance Summit  change management  corporate strategy  cross-industry collaborations  Ecosystems  IoT  joint ventures  partnering  programme management  strategic alliances  Thought Leader Global 

Share |
PermalinkComments (0)
 

Keynote Speaker “Dr. Sam” To Prescribe More Collaboration as Part of the Cure for US Heathcare Ailments at ASAP’s BioPharma Conference

Posted By Cynthia B. Hanson, Tuesday, August 30, 2016
Updated: Saturday, August 27, 2016

He’s a respected medical officer as well as a major mover and shaker in the area of healthcare reform. To those who know him personally, however, Dr. Sam Nussbaum is the wise and approachable “Dr. Sam.” The distinguished healthcare policy expert will be up on the podium at ASAP’s 2016 BioPharma Conference diagnosing woes and handing out prescriptions in relation to the changing political and healthcare scene in his talk “Healing the U.S. Health Care System: Collaboration is Essential” Wednesday, Sept. 7 at the conference “New Faces, Unexpected Places in Partnering: The Foresight to Lead, the Foundation to Succeed” at the Revere Hotel, Boston Common, Boston.

 

As a strategic consultant at EGB Advisors, Inc., the consulting arm for Epstein, Becker & Green, he advises healthcare, life science companies, physicians, hospitals, and provider organizations. He also served as the former executive vice president, clinical health policy, and chief medical officer at Anthem Health from 2000 to 2016, where he was acted as the key spokesperson and policy advocate and oversaw clinical strategy and corporate medical and pharmacy policy. He was responsible for HealthCore, Anthem's clinical outcomes research subsidiary, and helped create the model for the Food and Drug Administration’s Safety Sentinel System. Recognized by Modern Healthcare as one of the "50 Most Influential Physician Executives in Healthcare," he received the 2004 Physician Executive Award of Excellence from the American College of Physician Executives.

"Sam is the ‘advisor to healthcare advisors,’” says Brooke Paige, staff vice president, strategic initiatives at HealthCore, Inc. “He is sure to bring a dynamic energy and unique perspective to the ASAP Biopharma Conference. Sam is a true clinician, always keeping the patient in mind. As we talk about how our healthcare landscape may change in response to the upcoming presidential election, “Dr. Sam” can advise what potential election outcomes could mean for each segment of the industry."

 

Nussbaum is known for his exceptional role in creating collaborative solutions between Anthem, HealthCore, hospital systems, the FDA, and public agencies. He is well-versed in the value of partnering to solve systemic problems at the highest of levels, having helped design and promote patient-centered medical homes and assessed their impact on the quality and cost effectiveness of care. Under his leadership, HealthCore has built partnerships with federal agencies and academic institutions to advance drug safety, comparative effectiveness, and outcomes research.

“Dr. Nussbaum is uniquely qualified to discuss collaborative approaches and help attendees define ecosystem problems specific to their business while envisioning strategic partnering options to best address an alliance challenge,” says ASAP CEO Mike Leonetti, CSAP, of the choice. “We know as partnership professionals, that the US healthcare system will never be fixed without a collaborative approachit's just too complex not to bring the payors, providers, industry, and government participants together.  In addition, Nussbaum is a policy guru with strong healthcare policy experience and can help attendees prepare for a range of potential scenarios stemming from evolving healthcare policy impacted by the presidential elections.”

 

While serving at chief medical officer at WellPoint, he was accountable for $100 billion in healthcare expendituresfrom clinical pharmacy programs to care and disease management. The HealthCore subsidiary built partnerships during that time to further outcomes research, drug safety, and comparative effectiveness with large federal agencies, such as the Centers for Disease Control and FDA, as well as academic institutions.

 

He received his medical degree from Mount Sinai School of Medicine, and trained in internal medicine at Stanford University Medical Center and Massachusetts General Hospital. He also trained in endocrinology and metabolism at Harvard Medical School and Massachusetts General Hospital. He currently serves on the Board of Directors of the OASIS Institute, NEHI, BioCrossroads (an Indiana-based public-private collaboration that advances and invests in the life sciences), and America's Agenda. He is a member of the Scientific Advisory Board of Medidata, a publicly traded clinical technology company serving life sciences clients, and the Healthcare Advisory Board of KPMG. He serves as Chair of the Centers for Education & Research on Therapeutics (CERTs) Steering Committee (a cooperative agreement between AHRQ and the FDA), is a member the HHS Health Care Payment Learning and Action Network (LAN) Guiding Committee, and participates in Institute of Medicine activities, including serving on the Roundtable on Value & Science-Driven Health Care.

 

For more information about the 2016 ASAP BioPharma Conference and keynote speaker Sam Nussbaum, go to http://www.asapweb.org/biopharma/.

Tags:  Anthem Health  ASAP BioPharma Conference  collaborative solutions  Dr. Sam Nussbaum  EGB Advisors  FDA  healthcare  HealthCore  hospital systems  Inc.  life science companies  partnerships  public agencies  WellPoint 

Share |
PermalinkComments (0)
 

Sharing Insights and Successes at the 2017 Global Alliance Summit ASAP Issues Call for Topics and Presentations and Opens Nominations for 2017 Alliance Excellence Awards

Posted By Cynthia B. Hanson, Monday, August 29, 2016
Updated: Saturday, August 27, 2016

The ASAP Global Alliance Summit is a great place to learn, grow,  and network. It’s also a tremendous opportunity for your company and its workers to shine. Please pull up a chair at the programming table, brainstorm with us, and help ASAP create the world’s largest and most prestigious gathering of alliance executives. We’re asking you and your company to be part of our team and submit ideas to the Call for Topics & Presentations by September 15, 2016, the deadline for the 2017 ASAP Global Alliance Summit in San Diego, California, Feb. 28-March 2. If you have questions or comments about ASAP’s Call for Topics & Presentations, please visit our website at www.asapweb.org/cft 

While you’re at it, don’t forget to mark your calendars for the 2017 Global Alliance Summit to gain exclusive access to the most current models, methods, research, and practices, as well as metrics and tools in the part­nering and alliance management profession. Imbibe the latest developments and practices in the industry through powerful keynotes, presentations, and executive panels, as well as extensive networking opportunities.   


As the insider, you know what your company is up to behind the scenes. Maybe it needs to be made public and shared for others to emulate. It may be time for your company and colleagues to be recognized for exceptional alli­ance practices. Please consider submitting a nomination for the 2017 ASAP Alliance Excellence Awards, to be an­nounced at the 2017 ASAP Global Alliance Summit in San Diego. We want to hear about your successes
and so do others! Use the Quick Form for pre-screening, followed by completion of the standard, long form in a specific award category for review. Is your company having a significant so­cial impact through partnering? If so, consider submitting for the Corporate Social Responsibility Award. Let your colleagues know, too, about this exceptional award oppor­tunity. You can learn more about the submission process by going www.asapweb.org/awards.

Tags:  alliance  ASAP Alliance Excellence Awards  ASAP Global Alliance Summit  Call for Topics and Presentations  metrics  networking  partnering  practices  programming  research 

Share |
PermalinkComments (0)
 

New Offerings at ASAP BioPharma Conference Address Wide-ranging Impacts on the Healthcare and Life Sciences Industries

Posted By Cynthia B. Hanson, Saturday, August 27, 2016

As futuristic technologies become realities, professionals in the life sciences and healthcare industries are consulting their maps and charts to determine how their companies should navigate the new waters. Attendees at ASAP’s next BioPharma Conference will have an opportunity to collectively view the vast possibilities at “New Faces, Unexpected Places in Partnering: The Foresight to Lead, the Foundation to Succeed,” Sept. 7-9 at the Revere Hotel in Boston, Mass., USA. This year’s conference will address wide-ranging impacts on the industry, including the changing political scene, multi-partnering, the Internet of Things, and assistive technologies. 

 

After a rich offering of workshops on Sept. 7, the conference will kick off with a timely address from keynote speaker Dr. Sam Nussbaum, strategic consultant, EGB Advisors, Inc., who will present a talk on “Healing the U.S. Health Care System: Collaboration is Essential” (for more information about Nussbaum, see the link in this E-news), followed by a networking opportunity. The following two days include a plenary and about 26 forward-thinking, thought-provoking sessions from which to choose.

 

"The ASAP Biopharma Conference is a must-attend for alliance professionals of all experience levels,” says Jan Twombly, CSAP, former ASAP chairman of programming, and president of The Rhythm of Business. “It traditionally offers equal parts of looking outward to how the industry is changing and the implications for managing the risk and optimizing the value of alliances and other collaborations, as well as looking inward to develop the mindset, skillset, and toolset of a modern alliance capability.”

 

Well-known and respected industry luminaries are unveiling some never-before-presented information and perspectives. Take, for example, these insightful offerings:

  •  “Applying the Latest Alliance Management Research to Your Partnering Practice,” presented by Stuart Kliman, CA-AM, partner, alliance practice leader at Vantage Partners, and Shawn Wilson, DBA, vice president and general manager at Beaulieu Group: Two new groundbreaking research studies provide critical data on current trends, challenges, and opportunities in the alliance management profession.
  • “A New Model for Western and Chinese Pharmaceutical Partnering,” presented by Brent Harvey, CA-AM, director of Alliances, Eli Lilly and Company: "How To" insights on collaboration drawn from a longstanding, advanced partnership model between Eli Lilly and Company and WuXi AppTech, which provides, among other things, examples of how to leverage the regulatory environment in China to bring new drugs to market faster.
  • “New Partnerships between High Tech and BioPharma and the Alliance Management Practices to Support Them,” presented by Russ Buchanan, CSAP head of corporate alliances at Xerox Corporation, Joseph Schramm, VP strategic alliances at BeyondTrust, and David Thompson, CA-AM chief alliance officer at Eli Lilly and Company: Key insights provided by two highly accomplished technology company alliance executives that are sure to generate discussion about how biopharma alliance professionals can overcome potential challenges when partnering with tech companies.

 Preparing for rapid change is a central theme throughout the conference, and some of the workshops are offering essential “updates” for the alliance management toolbox. “With many more partners for many more purposes, new partnering models and differences to leverage, no alliance manager can rest on his or her laurels,” points out Twombly. “Unique among biopharma alliance management conferences, the ASAP Biopharma Conference leans in on where the profession is going, not where it has been."

 

Several workshops being offered emphasize the need to stay abreast of pressing industry changes, such as “Next Generation Alliance Management, Lean and Agile” facilitated by Lynda McDermott, CA-AM, president of EquiPro International, and Annick De Swaef, CSAP, managing partner of Consensa Consulting. Their workshop addresses digitalization’s influence on biopharma and cross-industry partnering, and it centers around basic questions that everyone in the industry is asking: “Are my team's current alliance best practices future proof? Should my alliance team acquire new skills?” De Swaef recommends combining ASAP’s newly launched in-company team training with the CA-AM Certification Exam Prep to strengthen company capabilities, expand into new areas of value creation, and introduce new best practices.

 

Twombly and Rhythm of Business Principal, Jeff Shuman, CSAP, are offering their own forward-thinking, 90-minute, hands-on workshop on design thinking for complex problems, such as for multi-partnering, non-asset-base alliances, and partnering with “sectors who run on much faster clock speeds than is typically seen in biopharma.” The data-driven, user experience-centered innovation and problem-solving methodology has been adapted for alliances and partnering practices.

 ASAP also plans to unveil a new custom-designed session: The ASAP Aquarium, facilitated by Twombly. Similar to a “fishbowl” communications activity, where the line is intentionally blurred between listeners and participants, ASAP’s version will start off with a deep discussion between industry thought leaders and senior-level partnering executives as the audience gazes into the aquarium. Listeners will then be able to “tap in,” join the discussion with a hot idea or new perspective, and replace the initial participants. The session provides for a fun way to actively engage and contribute to the collective wisdom of the group while exploring the questions that matter most as alliance professionals “engage with new faces and in unexpected places.”

Tags:  Alliance Professionals  Annick De Swaef  ASAP BioPharma Conference  BeyondTrust  Brent Harvey  collaboration  David Thompson  Dr. Sam Nussbaum  Eli Lilly and Company  EquiPro International  Jan Twombly  Jeff Shuman  Joseph Schramm  Lynda McDermott  Russ Buchanan  The Rhythm of Business  WuXi AppTech  Xerox 

Share |
PermalinkComments (0)
 

Maximizing the Alliance Management and C-Suite Relationship Through the Eyes of Biopharma Conference Plenary Speaker Stéphane Thiroloix

Posted By Cynthia B. Hanson, Monday, August 1, 2016
Updated: Sunday, July 31, 2016

Stéphane Thiroloix describes himself as a “reasonable generalist,” having been involved with partnering in multiple waysfrom business development, general management, marketing, and sales to R&D and legal affairs. The CEO at Mayoly Spindler, an emerging family-owned, independent French company with a focus on gastroenterology and dermocosmetics, will present a plenary talk on The View from the C-Suite: Partnering and Alliances Today and Tomorrow,” Thursday morning, Sept. 8, during the 2016 ASAP BioPharma Conference. This year’s conference, “New Faces, Unexpected Places in Partnering: The Foresight to Lead, the Foundation to Succeed,” will be held Sept. 7-9 at the Revere Hotel in Boston. Mayoly Spindler’s revenue originates half in France and half abroad through activities in over 50 countries, mostly via local partnerships. The company’s portfolio strategy is based almost exclusively on partnering. Thiroloix provided this preview of his topic on how alliance management functions can best be viewed and leveraged by company senior leadership.

What are some of the challenges when coordinating the alliance management and C-Suite relationships?
The first challenge is simply understanding the role of alliance management. When you have skilled and proactive alliance managers, it does not take long for the C-Suite to appreciate their work and turn to them constantly. Another challenge is keeping the alliance manager in play at all times, even when a partner is tempted to take a more direct CEO-to-CEO route. While that’s a perfectly legitimate move, it’s then the CEO's responsibility to keep the alliance manager in play, even if it’s transiently unofficial. One interesting challenge is accepting contradictions from the alliance manager as they stand for partner interests. It’s easy to state and posture that the alliance manager is our partner's ambassador in our ExCom [executive committee], but when they make the partner's case in a difficult decision, we may feel a little strain as we remind ourselves that we hired them to do so and should pay attention.

Among your proposed discussion topics is the importance of establishing an alliance management function and its value to the senior executive team. Why has this become increasingly important in the new ecosystem?
The pharma model has become tremendously fragmented. When I started my professional life, large pharma companies were the norm, and they were fully integrated—from fundamental research to sales. Partnerships were the exception rather than the norm, and we relied mostly on our internal dynamics to succeed. Today, not only is there a constellation of small, ultra-specialized players, but even the large pharma players outsource vast quantities of strategic activities, including entire components of their R&D, most of their manufacturing, and frequently their commercial activity. As a result, the way we work today is intrinsically alliance-based. Additionally, it’s not about whether you're big or small. If you are a big, dominant player, there is high risk that you will be overpowering in your partnerships. Partners used to accept this because partnering with big pharma was the grail. That’s no longer the case, so big players need alliance management to maintain a healthy balance in their dealings with smaller players who have a variety of other doors to knock on. If you are a small player, you must be agile, humble, and alliance-focused in order to quickly build a strong partnering track record.

Describe some effective strategies partnering professionals can use to support the C-Suite?
A straight answer may be a little simplistic. The company (and its C-Suite), its partners and the alliance manager themselves, have a specific profile and style that may call for different approaches. The C-Suite requires a difficult balance between boring them with systematic activity reporting and appearing to withhold knowledge that provides an edge—which is unbearable to the C-Suite. What I've seen work well is to use the pace of partnership governance: at ExCom meetings before key alliance governance moments, provide relevant updates and gather C-Suite insight. That way you will not be covering all topics all the time. Make sure you share partner milestones to provide the C-Suite with opportunities to react in a constructive manner. If a partner cleared an FDA hurdle or raised capital, some C-Suite members may want to send a congratulatory note—but if you don’t point it out, they might miss the occasion. The best way to work the C-Suite is unquestionably to work more with their teams than with them. Similarly, make sure the C-Suite's personal assistants know where to find alliance reports, and develop flexibility and opportunities for them to connect with bosses whenever they need to deal with the alliance. Be ready to explain the same things again and again. And never, ever surprise them.

Tags:  alliance management  alliances  C-Suite  ecosystem  FDA  governance  Mayoly Spindler  partners  partnership  Stéphane Thiroloix 

Share |
PermalinkComments (0)
 
Page 35 of 81
 |<   <<   <  30  |  31  |  32  |  33  |  34  |  35  |  36  |  37  |  38  |  39  |  40  >   >>   >| 
For more information email us at info@strategic-alliances.org or call +1-781-562-1630